STAT
APRIL 30, 2023
In 2009, when President Barack Obama was touring the country and ginning up support for what would eventually become the Affordable Care Act, Geisinger entered the mainstream. Obama praised Geisinger , the rural Pennsylvania hospital system and health insurer “where high-quality care is being provided at a cost well below the national average.
LifeProNow
APRIL 30, 2023
April 28, 2023: “The Food and Drug Administration’s Oncologic Drugs Advisory Committee (ODAC) has recognised a favourable benefit risk profile for AstraZeneca and MSD’s Lynparza (olaparib) plus abiraterone and prednisone or prednisolone for the treatment of adult patients with BRCA-mutated (BRCAm) metastatic castration-resistant prostate cancer (mCRPC) based on the PROpel Phase III trial.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
ID Stewardship
APRIL 30, 2023
In this article advice for new pharmacists is provided by a pharmacist with 15 years of experience and answers are sourced from commentary on Twitter as well. Composed By: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article Posted 1 May 2023 Recently while attending the American Pharmacist Association’s annual meeting in Phoenix, AZ I walked by a grown man at a breakfast bar wearing a head-to-toe onesie patterned with Dunkin’ Doughnuts (DD) logos.
LifeProNow
APRIL 30, 2023
April 29, 2023: “Astellas Pharma Inc. and Pfizer Inc. announced that XTANDI® (enzalutamide) plus leuprolide significantly reduced the risk of metastasis or death by 58% versus placebo plus leuprolide (Hazard Ratio [HR]: 0.42; 95% Confidence Interval [CI], 0.30–0.61; P<0.0001), as assessed by the primary endpoint of metastasis-free survival (MFS), in men with non-metastatic hormone-sensitive prostate cancer (nmHSPC; also known as non-metastatic castration-sensitive prostate cancer or nm
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Joe
APRIL 30, 2023
In this episode, I’ll discuss giving lactated ringer’s solution to a patient with elevated lactate. Episode 813: Can you give lactated ringer’s solution to a patient with elevated lactate? Subscribe on iTunes , Android , or Stitcher Lactated ringers is considered a suitable fluid for resuscitation in sepsis. In fact, it is becoming more common to use it as a resuscitation fluid as it contains a more physiologic level of chloride than normal saline and is not expected to cause hyperchlorem
The Luxe Pharmacist
APRIL 30, 2023
Hi babes, In my book there is nothing better than girl time and anything beauty related, so you cannot beat a spa get away with your girl friends if you ask me! My girl friend Steph and I got to check out the newly renovated Cerulean Spa at the Mystic Marriott Hotel and it was an absolute dream. Mystic is one of my favorite towns in Connecticut and is especially beautiful in the warmer months since it’s right on the coast.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
The Guardian - Pharmaceutical Industry
APRIL 30, 2023
A powerful new weight-loss medication may be approved for those aged 12 to 17. But healthcare professionals fear it ignores the underlying socioeconomic causes Like many GPs around the UK, Semiya Aziz has grown accustomed to seeing children as young as four or five who are obese. Knowing how best to address this delicate and complex issue with parents, given the time constraints of a 10-minute consultation, is a challenge for GPs, who are increasingly shouldering the burden of the UK’s burgeonin
Med Ed 101
APRIL 30, 2023
Our Meded101 NAPLEX material is ready for 2023 participants, and it is about the time of year that students are gearing up for the NAPLEX. I wanted to provide a really nice discount on our massive study package. I recall what it was like to prepare for the NAPLEX and how funds were tight toward […] The post BIG NAPLEX Discount – One Time Only!
The Guardian - Pharmaceutical Industry
APRIL 30, 2023
Department of Health asks watchdog to assess effectiveness of giving semaglutide to obese youngsters aged 12 to 17 Children as young as 12 in England could be given weight-loss injections on the NHS after the government asked medical watchdog Nice to assess the potential benefits of prescribing them to under-18s. Department of Health officials have asked the watchdog to evaluate the clinical and cost effectiveness of giving semaglutide injections to obese children aged 12 to 17, “in addition to
FDA Law Blog: Biosimilars
APRIL 30, 2023
By Kurt R. Karst & Michael D. Shumsky — On May 2nd, the U.S. Senate Committee on Health, Education, Labor and Pensions (“Senate HELP”) is scheduled to take up legislation that could significantly limit access to the courts and immunize critical FDA decisions from timely judicial review. That bill is S. 1067, the “ Ensuring Timely Access to Generics Act of 2023 ,” and it would fundamentally transform the playing field for NDA, ANDA, BLA, and aBLA applicants seeking to preserve their rights i
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
PharmaTech
APRIL 30, 2023
In this podcast, Kayleigh Hearse, Sr Mgr. Technical Projects, Capacity Expansion Pharma Production shares details of Baxter BioPharma Solution’s approximately $100 million expansion of its sterile fill/finish manufacturing facility located in Halle/Westfalen, Germany. Kayleigh explains many of the key attributes of the new building, key learnings and major considerations that took place throughout the planning phase.
Pharmacy Times
APRIL 30, 2023
Clinical interventions, follow-ups, medication reconciliation, patient education are key aspects of the programs.
PharmaTech
APRIL 30, 2023
In this podcast, Kayleigh Hearse, Sr Mgr. Technical Projects, Capacity Expansion Pharma Production shares details of Baxter BioPharma Solution’s approximately $100 million expansion of its sterile fill/finish manufacturing facility located in Halle/Westfalen, Germany. Kayleigh explains many of the key attributes of the new building, key learnings and major considerations that took place throughout the planning phase.
Drug Patent Watch
APRIL 30, 2023
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Romania. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating… The post Which pharmaceutical companies have the most SPCs in Romania? appeared first on DrugPatentWatch - Make Better Decisions.
Expert insights. Personalized for you.
258 
Let's personalize your content